Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
embecta
MedTech
Embecta to buy auto-injector maker Owen Mumford for $200M
Embecta has agreed to pay 100 million pounds sterling upfront for the company, or about $134.3 million, plus 50 million pounds in sales milestones.
Conor Hale
Mar 19, 2026 4:30pm
Embecta shutters insulin patch pump program amid restructuring
Nov 26, 2024 12:52pm
Embecta's insulin patch pump secures FDA nod in Type 2 diabetes
Sep 3, 2024 2:29pm
BD cuts 60 jobs at Irish site to ‘right-size’ manufacturing
Jul 5, 2023 11:25am
Embecta dives into Type 2 diabetes tech with Tidepool team-up
May 15, 2023 12:24pm
Embecta beats its own estimates in first 6 months of BD spinout
Dec 22, 2022 11:07am
